These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12420081)

  • 1. QT prolongation in patients with Type 2 diabetes and microalbuminuria.
    Rutter MK; Viswanath S; McComb JM; Kesteven P; Marshall SM
    Clin Auton Res; 2002 Oct; 12(5):366-72. PubMed ID: 12420081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
    Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
    Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of QT dispersion and 24 hour ambulatory blood pressure monitoring amongst diabetic patients with and without microalbuminuria.
    Yeo CK; Hapizah MN; Khalid BA; Wan Nazainimoon WM; Khalid Y
    Med J Malaysia; 2004 Jun; 59(2):185-9. PubMed ID: 15559168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm.
    Deyneli O; Ersöz HO; Yavuz D; Fak AS; Akalin S
    Diabetes Obes Metab; 2005 Mar; 7(2):136-43. PubMed ID: 15715886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with Type 1 diabetes.
    Karavanaki K; Kazianis G; Kakleas K; Konstantopoulos I; Karayianni C
    Diabet Med; 2007 Nov; 24(11):1247-53. PubMed ID: 17672861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced changes in QT interval duration and dispersion in patients with isolated myocardial bridging.
    Barutcu I; Sezgin AT; Gullu H; Topal E; Acikgoz N; Ozdemir R
    Int J Cardiol; 2004 Apr; 94(2-3):177-80. PubMed ID: 15093977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal.
    Sigdel M; Rajbhandari N; Basnet S; Nagila A; Basnet P; Tamrakar BK
    Nepal Med Coll J; 2008 Dec; 10(4):242-5. PubMed ID: 19558062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient.
    Yamagami K; Hosoi M; Yamamoto T; Fukumoto M; Yamakita T; Miyamoto M; Yoshioka K; Ishii T; Sato T; Tanaka S; Fujii S
    Diabetes Obes Metab; 2005 Jul; 7(4):390-6. PubMed ID: 15955125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.
    Linnemann B; Janka HU
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):215-22. PubMed ID: 12845560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M; Gross JL; Silveiro SP
    J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
    Gomes MB; Nogueira VG
    Diabetes Res Clin Pract; 2004 Oct; 66(1):31-9. PubMed ID: 15364159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes mellitus in Singapore.
    Wu AY; Tan CB; Eng PH; Tan KT; Lim SC; Tan EK
    Singapore Med J; 2006 Apr; 47(4):315-20. PubMed ID: 16572244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.